ANGEL MATTHEW (CEO and President) purchased 231.48K shares of TEMPEST THERAPEUTICS, INC. on the open market
Open‑market purchase worth $500.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/25/2026ACC: 0001931356-26-000011
DirectorOfficer10% Owner· CEO and President
Since Feb 2026
+231.48K
Net shares
Net buyer
$500.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
231.48K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+231.48K
Price / share
$2.16
Trade value
$500K
% of position
New position
3/24/2026
0.00→231.48K
Total
Net shares
+231.48K
Net value
$500K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/24/2026 | P · Purchase | +231.48K | $2.16 | $500K | New position | 0.00 | 231.48K |
| Total | +231.48K | $500K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned4.84M
Total
4.84M direct4.84M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.84M | Direct |
| Total | 4.84M | 4.84M direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported